First Mercantile Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,535
Closed -$232K 898
2020
Q3
$232K Sell
1,535
-165
-10% -$21.6K 0.03% 359
2020
Q2
$197K Buy
+1,700
New +$196K 0.02% 406
2016
Q4
Sell
-667
Closed -$84K 905
2016
Q3
$84K Sell
667
-7,405
-92% -$915K 0.01% 751
2016
Q2
$943K Sell
8,072
-608
-7% -$68.8K 0.12% 234
2016
Q1
$899K Sell
8,680
-1,262
-13% -$122K 0.11% 244
2015
Q4
$990K Sell
9,942
-2,248
-18% -$220K 0.1% 259
2015
Q3
$1.11M Sell
12,190
-664
-5% -$66.6K 0.11% 241
2015
Q2
$1.36M Sell
12,854
-757
-6% -$83.8K 0.12% 221
2015
Q1
$1.55M Sell
13,611
-516
-4% -$58.9K 0.13% 194
2014
Q4
$1.56M Sell
14,127
-257
-2% -$27.1K 0.13% 194
2014
Q3
$1.41M Sell
14,384
-1,258
-8% -$124K 0.11% 222
2014
Q2
$1.58M Sell
15,642
-2,071
-12% -$202K 0.13% 219
2014
Q1
$1.63M Sell
17,713
-5,293
-23% -$488K 0.12% 233
2013
Q4
$2.08M Sell
23,006
-91
-0.4% -$7.88K 0.16% 154
2013
Q3
$1.84M Sell
23,097
-836
-3% -$65.8K 0.15% 170
2013
Q2
$1.74M Buy
+23,933
New +$1.79M 0.15% 177

Other funds holding ZBH

First Mercantile Trust's ZBH Position: Q4 2020 in Review

First Mercantile Trust sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 1,535 shares — an estimated $232K sold.

First Mercantile Trust first reported a position in ZBH in Q2 2013 and held it in 16 quarters. The position peaked at $2.08M in Q4 2013. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • First Mercantile Trust reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • First Mercantile Trust sold 1,535 Zimmer Biomet shares in Q4 2020, an estimated $232K.
  • First Mercantile Trust first reported a position in Zimmer Biomet in Q2 2013 and held it in 16 quarters.
  • First Mercantile Trust's Zimmer Biomet position peaked at $2.08M in Q4 2013.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on First Mercantile Trust's 13F filing for Q4 2020, filed 11 Feb 2021.